1-2 of 2
Ivy NJ Hung, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies

Peggy A Thompson, PhD, Boreth Eam, Nathan P Young, PhD, Sarah Fish, Joan Chen, PhD, Maria Barrera, Haleigh Howard, Ana Parra, Jolene Molter, Jocelyn Staunton, Ivy NJ Hung, PhD, Greg S Parker, PhD, Gary G Chiang, PhD, Chris J Wegerski, PhD, Andres Nevarez, Jeff Clarine, Sam Sperry, PhD, Alan Xiang, PhD, Chinh Tran, Christian Nilewski, PhD, Garrick K Packard, PhD, Theodore Michels, PhD, Paul A Sprengeler, PhD, Justin T Ernst, PhD, Siegfried H Reich, PhD, Kevin R Webster, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1530.
https://doi.org/10.1182/blood.V130.Suppl_1.1530.1530
Published: 2017
Journal Articles

eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Kevin R. Webster, PhD, Vikas K Goel, PhD, Ivy NJ Hung, PhD, Gregory S Parker, PhD, Jocelyn Staunton, BA, Melissa Neal, Jolene Molter, Gary G Chiang, PhD, Katti A. Jessen, PhD, Christopher J Wegerski, PhD, Samuel Sperry, PhD, Vera Huang, PhD, Joan Chen, PhD, Peggy A Thompson, PhD, James R Appleman, PhD, Stephen E Webber, PhD, Paul A Sprengeler, PhD, Siegfried H Reich, PhD
Journal: Blood
Blood (2015) 126 (23): 1554.
https://doi.org/10.1182/blood.V126.23.1554.1554
Published: 2015